The clinical information you need, at your fingertips.

First over-the-counter apraclonidine eye drop offers a new option for temporary redness relief without a prescription. . .

Embedded decision support modestly reduced falls and fall-related injuries without adding major workflow burden. . .

Benefits extended beyond readmissions, but only when clinicians actively reviewed and acted on patient-reported data. . .

First automated, once-daily delivery option could improve treatment flexibility for adults with anti-AChR antibody-positive disease. . .

Simple device-free auricular acupressure added to standard treatment improved rosacea control, reduced flare-related vascular changes, and lowered inflammatory biomarkers. . .

Consumer wearable identified moderate-to-severe OSA in a validation study, with especially strong performance in high-risk patients. . .